December 17, 2024
Appeals require additional documentation, often including specialist referrals (endocrinologist, bariatric physician), more detailed medical history, and sometimes peer-reviewed studies supporting medication use for your specific case
The most common adverse events are transient gastrointestinal disturbances (nausea, diarrhea, constipation, vomiting) occurring predominantly during dose escalation
Lancet 405 , 15801593 (2025)
By adjusting your eating habits to align with your bodys new signals, you can greatly minimize discomfort and enhance your results
Combination therapies Besides the combination therapies described above, in patients with bridging fibrosis and cirrhosis, combining cilofexor (ACC inhibitor) and firsocostat (FXR agonist) for 48 weeks was well tolerated, showed beneficial effects on MASH disease parameters, and might improve fibrosis